The ratio of adaptive to innate immune cells differs between genders and associates with improved prognosis and response to immunotherapy

HIGHLIGHTS

• who: Johanne Ahrenfeldt et al. from the Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark, Department of Clinical have published the research: The ratio of adaptive to innate immune cells differs between genders and associates with improved prognosis and response to immunotherapy, in the Journal: PLOS ONE of March/25,/2022
• what: Interestingly this difference is no longer significant when the authors focus on patients treated by immunotherapy. The study provides a potential link between increased cancer-associated mortality among males and a relatively lower ratio of adaptive-to-innate immune cells in the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.